Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. - Wikidata - awgldk - TriplyDB

Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings.

Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings.

http://www.wikidata.org/entity/Q31119394

about

Microscopic-observation drug-susceptibility assay for the diagnosis of TB Recent advances in the diagnosis and treatment of childhood tuberculosis Diagnosis & treatment of tuberculosis in HIV co-infected patients.Clinical research and development of tuberculosis diagnostics: moving from silos to synergy Diagnosis and management of miliary tuberculosis: current state and future perspectives Solar disinfection of MODS mycobacterial cultures in resource-poor settings Evaluation of the MODS culture technique for the diagnosis of tuberculous meningitis Development of low-cost inverted microscope to detect early growth of Mycobacterium tuberculosis in MODS culture Simplified automated image analysis for detection and phenotyping of Mycobacterium tuberculosis on porous supports by monitoring growing microcolonies Genetic diversity of Mycobacterium tuberculosis in Peru and exploration of phylogenetic associations with drug resistance A field evaluation of the Hardy TB MODS Kit™ for the rapid phenotypic diagnosis of tuberculosis and multi-drug resistant tuberculosis Transmission of Multidrug-Resistant and Drug-Susceptible Tuberculosis within Households: A Prospective Cohort Study Protocol for studying cough frequency in people with pulmonary tuberculosis.Dynamics of Cough Frequency in Adults Undergoing Treatment for Pulmonary Tuberculosis.Facing the crisis: improving the diagnosis of tuberculosis in the HIV era.Development of an automated MODS plate reader to detect early growth of Mycobacterium tuberculosis.La cuerda dulce--a tolerability and acceptability study of a novel approach to specimen collection for diagnosis of paediatric pulmonary tuberculosis.Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis.Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis.Evaluation of molecular tools for detection and drug susceptibility testing of Mycobacterium tuberculosis in stool specimens from patients with pulmonary tuberculosis.Infrequent MODS TB culture cross-contamination in a high-burden resource-poor setting.Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru.Microscopic observation drug susceptibility assay for tuberculosis screening before isoniazid preventive therapy in HIV-infected persons Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant tuberculosis in Viet Nam.Diagnostic accuracy of the microscopic observation drug susceptibility assay: a pilot study from India.Genetic diversity and transmission characteristics of Beijing family strains of Mycobacterium tuberculosis in Peru Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay Early and efficient detection of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures.New specimens and laboratory diagnostics for childhood pulmonary TB: progress and prospects.Validation of microscopic observation drug susceptibility testing for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving tuberculosis treatment.Reliability of the MODS assay decentralisation process in three health regions in Peru.MODS accreditation process for regional reference laboratories in Peru: validation by GenoType® MTBDRplus.Diagnosis of tuberculosis: the experience at a specialized diagnostic laboratory The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis Prolonged infectiousness of tuberculosis patients in a directly observed therapy short-course program with standardized therapy.Microscopic Observation Drug Susceptibility Assay for Rapid Diagnosis of Lymph Node Tuberculosis and Detection of Drug Resistance Genomics and the evolution, pathogenesis, and diagnosis of tuberculosis.Rationing tests for drug-resistant tuberculosis - who are we prepared to miss?Prospective evaluation of simply modified MODS assay: an effective tool for TB diagnosis and detection of MDR-TB.Co-infection with human immunodeficiency virus and tuberculosis in Asia

P2860

Q24683727-5F35B4D4-BED6-4D40-98EC-039B7034C5E0 Q26797426-7C924D07-4EFA-4BD5-B58A-21C59308E772 Q26991633-BBA6F7D6-4CC2-4499-A7D6-D90FD9229226 Q28383710-7A820A9C-8040-4815-A558-25C9AF0DC076 Q28393022-ACD19DEE-2784-4960-84B8-2C239D4C6BF7 Q28469344-3097A9D0-D5D8-4370-A761-EE76866233B6 Q28471599-E81B9F83-F76D-4CA5-AE5D-5D7AA4C5C17D Q28473345-E15351BF-49DC-4A61-9B36-5CB72612A382 Q28474323-60A83739-1D65-4775-BA45-CDE8D2F1B06C Q28534210-A1B09534-541B-4C0D-9076-93311E9B8E76 Q28543017-8EC71D45-CFDD-4488-A27A-4EC2C57B054A Q28548584-F036CAE6-C6BC-4953-A3A5-B148E67CB1BB Q28603361-11924E71-22EC-47FF-B447-2BA81BBEBE25 Q30357938-DA1D45A8-AB13-4660-94A7-585B2AEBC2FC Q30362861-3EF8DBCC-C17C-4D57-A2D8-2F1AEA8AD9F4 Q30996659-EFE03564-C2E8-46BA-917C-0DFFE565D64A Q33238890-29BC838E-F481-4BAE-9488-14FCA3BD148D Q33270256-82EB1675-AC58-4D0E-8160-CAB4F3B5A3F7 Q33449024-6DE5995E-B834-4D59-BEE5-F6A38A919E91 Q33827194-7A2C10F3-E5F2-4F78-B471-76ED12678547 Q34030002-4937F82A-B53A-4368-A0F9-FD2554689F67 Q34030008-CFEA6E6F-9750-4CC2-8F52-C1EA62D85412 Q34163313-613793BE-154E-4FA7-BE97-0864626B2C71 Q34178450-679FE191-8BDC-4657-A8BE-3B4B71532E04 Q34185356-12CF81DF-7AE7-41EB-9556-57F3F399B423 Q34490327-266C6D72-1706-4264-A5FF-114E3BF981D6 Q34604407-96906875-5D01-4476-A64A-10C9059AAA51 Q34612188-B7EAFACF-3679-43F1-8379-27AC2111009E Q34644528-E7AB89EB-1AAC-4DCC-ADE6-B78746F65501 Q34997131-001411B0-9B34-4E52-B997-ED910E333850 Q35012318-ACA4D431-B08C-4F5A-A7FB-274CC6F48868 Q35012329-0BA91663-F82B-4A22-B656-CFE92D799FBD Q35586498-8F84AC73-87D9-42AE-B114-D6EED4288C28 Q35660319-FB7AC44D-25A0-46C9-A7A9-B336AC8FC8A6 Q35736494-4B250F41-F32E-4BB6-B732-17ADEB579A78 Q35825295-DDC9A7B8-3108-42AF-BF76-091B1256C922 Q35865386-A7601A6A-22B4-4D9D-8512-5CA3A6A994FF Q35966925-467A9105-CA74-4B4B-964B-934F0496E0EF Q35982602-095BA4A2-0B1F-42F2-AD35-5B92DD10397C Q36074442-D4605D92-7B86-451A-95E4-2B4199336FEE

P2860

Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings.

http://www.wikidata.org/entity/Q31119394

description

2004 nî lūn-bûn

@nan

2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Microscopic observation drug s ...... use in resource-poor settings.

@ast

Microscopic observation drug s ...... use in resource-poor settings.

@en

type

label

Microscopic observation drug s ...... use in resource-poor settings.

@ast

Microscopic observation drug s ...... use in resource-poor settings.

@en

prefLabel

Microscopic observation drug s ...... use in resource-poor settings.

@ast

Microscopic observation drug s ...... use in resource-poor settings.

@en

P1433

Q31119394-BF2AF9E4-5C41-4280-8E5F-EBBDBA9F92B3

P1476

Q31119394-048D5CE0-610F-47B6-8E95-93F456FFDEB9

P2093

Q31119394-48FEA1ED-E717-42FB-8821-D0CC7A82662B

Q31119394-616D1675-0F14-4078-90AF-C2502CB72769

Q31119394-6B1F42CC-EA40-4EDF-B0A9-2EE917302CA3

Q31119394-AEF4269E-4ABD-4391-86EF-72668F42C336

Q31119394-AFEAFC2D-8F58-4250-8CA1-521D6955EE86

Q31119394-B8B045D5-13E3-4129-BC08-BCC73129A6C3

Q31119394-B9DB3018-C775-4458-822F-1B5E2B38D1CA

Q31119394-D904116D-C469-48BE-9BDB-CAF5D9EB1092

Q31119394-DBDF67B7-0CB1-4E6A-8CFA-1633F43F73D3

P2860

Q31119394-04A8C5F3-02E1-48AD-B932-888DBEAF1487

Q31119394-18EFCC03-584E-45D8-A3BD-B4D13DDBBF74

Q31119394-2735981E-8DFA-4885-84B9-AC796D361A5E

Q31119394-369C500A-F944-45B1-80AF-52AEF2E14EA9

Q31119394-372746C1-C423-4465-ADC7-21071755B7EE

Q31119394-3A4ED4CA-C2D8-4245-8D4E-177C803A04BF

Q31119394-3EA72DF6-E746-4367-A66C-EABE43D0FF89

Q31119394-77DF574F-B428-48F7-BA18-74893D79181F

Q31119394-7EE21EA8-6828-4192-95F6-E25402E9AF50

Q31119394-82B1C040-C154-4E82-BC67-49810E008D6F

P304

Q31119394-6791AA63-0681-45E5-AE35-BE049C1241CA

P31

Q31119394-5848A915-A097-4DC8-929C-3C124FA2B27E

P356

Q31119394-ADD0E60A-0A5F-4791-BEC9-73A2568BF710

P407

Q31119394-481A7FA3-C109-495C-9544-3B0442A83072

P433

Q31119394-AF3944A5-0811-47C2-95CA-D1B471162655

P478

Q31119394-9929D4A7-AC08-4802-96B1-FF236C7762E3

P50

Q31119394-14574972-5DB5-480F-A05F-9FDBDC6F4777

Q31119394-6DB05495-175A-471C-A5F9-3F9DCE1AFF46

Q31119394-B7DFBF02-3A55-4373-8EB9-0BEC3096C763

Q31119394-E6333B56-43B5-4C27-9E4B-2E0F21EB075F

P577

Q31119394-FA619DEB-1B0B-4B7B-9866-7C41EB942E90

P5875

Q31119394-32D1D22A-4CB3-4406-8941-E3B999FCE33F

P698

Q31119394-FBBF42E5-2999-4560-ABC5-0E2BD9FE276C

P921

Q31119394-4089F62C-D422-48CD-A204-8A22019470C4

Q31119394-E32CB730-CC38-42E6-B362-2A537F9844AC

Q31119394-bec7cc97-04d4-4a49-8196-c83b9214983b

P932

Q31119394-4B50C036-ABAB-4F92-997B-FFD51954A390

P356

JCM.42.10.4432-4437.2004

P1433

Journal of Clinical Microbiology

P1476

Microscopic observation drug s ...... use in resource-poor settings.

@en

P2093

Daniel Vargas

http://www.w3.org/2001/XMLSchema#string

David A J Moore

http://www.w3.org/2001/XMLSchema#string

Giselle Soto

http://www.w3.org/2001/XMLSchema#string

Jaime Ortiz

http://www.w3.org/2001/XMLSchema#string

Jose Guerra

http://www.w3.org/2001/XMLSchema#string

Jose Serpa

http://www.w3.org/2001/XMLSchema#string

Luz Caviedes

http://www.w3.org/2001/XMLSchema#string

María-Graciela Hollm Delgado

http://www.w3.org/2001/XMLSchema#string

Tuberculosis Working Group in Peru

http://www.w3.org/2001/XMLSchema#string

P2860

Statistical methods for assessing agreement between two methods of clinical measurement

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin

Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium

Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay

Use of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide for rapid detection of rifampin-resistant Mycobacterium tuberculosis

Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus".

Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru

Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli.

Performance of the microscopic observation drug susceptibility assay in drug susceptibility testing for Mycobacterium tuberculosis.

P304

4432-4437

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.42.10.4432-4437.2004

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P50

Carlton A. Evans

Robert H Gilman

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8244053

http://www.w3.org/2001/XMLSchema#string

P698

15472289

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

multiple drug resistance

P932

522377

http://www.w3.org/2001/XMLSchema#string